Cytokinetics Inc. (CYTK) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $60.82 +0.15%
EPS Growth %: +43.1%
Financial Fact:
Research and development: 19.34M
Today's EPS Names:
OMID, SICP, SCKT, More
EPS Growth %: +43.1%
Financial Fact:
Research and development: 19.34M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Cytokinetics Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CTS Corp. (CTS) Tops Q3 EPS by 10c ; Offers Guidance
- Royal Caribbean (RCL) Tops Q3 EPS by 19c; offers guidance
- Xylem (XYL) Misses Q3 EPS by 1c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
